vs

Side-by-side financial comparison of Cytek Biosciences, Inc. (CTKB) and FLUSHING FINANCIAL CORP (FFIC). Click either name above to swap in a different company.

Cytek Biosciences, Inc. is the larger business by last-quarter revenue ($62.1M vs $58.8M, roughly 1.1× FLUSHING FINANCIAL CORP). FLUSHING FINANCIAL CORP runs the higher net margin — 6.8% vs -70.9%, a 77.8% gap on every dollar of revenue. On growth, FLUSHING FINANCIAL CORP posted the faster year-over-year revenue change (2597.7% vs 8.1%). FLUSHING FINANCIAL CORP produced more free cash flow last quarter ($55.8M vs $-1.8M). Over the past eight quarters, Cytek Biosciences, Inc.'s revenue compounded faster (17.7% CAGR vs 13.7%).

Cytek Biosciences, Inc. develops, manufactures and sells high-performance flow cytometry systems, associated reagents and analysis software. Its solutions serve life science research, clinical diagnostics and biopharmaceutical sectors, with a global customer base across North America, Europe and the Asia-Pacific region.

Flagstar Bank, N.A. (FLG), is an American regional financial services holding company headquartered in Hicksville, New York. In 2023, the bank operated 395 branches However, they rebranded all of these under the Flagstar name on February 21, 2024.

CTKB vs FFIC — Head-to-Head

Bigger by revenue
CTKB
CTKB
1.1× larger
CTKB
$62.1M
$58.8M
FFIC
Growing faster (revenue YoY)
FFIC
FFIC
+2589.5% gap
FFIC
2597.7%
8.1%
CTKB
Higher net margin
FFIC
FFIC
77.8% more per $
FFIC
6.8%
-70.9%
CTKB
More free cash flow
FFIC
FFIC
$57.6M more FCF
FFIC
$55.8M
$-1.8M
CTKB
Faster 2-yr revenue CAGR
CTKB
CTKB
Annualised
CTKB
17.7%
13.7%
FFIC

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
CTKB
CTKB
FFIC
FFIC
Revenue
$62.1M
$58.8M
Net Profit
$-44.1M
$4.0M
Gross Margin
52.9%
Operating Margin
-9.0%
13.3%
Net Margin
-70.9%
6.8%
Revenue YoY
8.1%
2597.7%
Net Profit YoY
-557.1%
108.2%
EPS (diluted)
$0.12

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CTKB
CTKB
FFIC
FFIC
Q4 25
$62.1M
$58.8M
Q3 25
$52.3M
$58.6M
Q2 25
$45.6M
$63.5M
Q1 25
$41.5M
$58.1M
Q4 24
$57.5M
$2.2M
Q3 24
$51.5M
$51.9M
Q2 24
$46.6M
$47.0M
Q1 24
$44.9M
$45.5M
Net Profit
CTKB
CTKB
FFIC
FFIC
Q4 25
$-44.1M
$4.0M
Q3 25
$-5.5M
$10.4M
Q2 25
$-5.6M
$14.2M
Q1 25
$-11.4M
$-9.8M
Q4 24
$9.6M
$-49.2M
Q3 24
$941.0K
$8.9M
Q2 24
$-10.4M
$5.3M
Q1 24
$-6.2M
$3.7M
Gross Margin
CTKB
CTKB
FFIC
FFIC
Q4 25
52.9%
Q3 25
52.7%
Q2 25
52.3%
Q1 25
48.6%
Q4 24
58.5%
Q3 24
56.3%
Q2 24
54.6%
Q1 24
51.3%
Operating Margin
CTKB
CTKB
FFIC
FFIC
Q4 25
-9.0%
13.3%
Q3 25
-17.6%
23.4%
Q2 25
-23.3%
29.8%
Q1 25
-36.1%
-10.2%
Q4 24
5.2%
-3296.2%
Q3 24
-8.2%
22.1%
Q2 24
-18.3%
15.2%
Q1 24
-23.9%
11.0%
Net Margin
CTKB
CTKB
FFIC
FFIC
Q4 25
-70.9%
6.8%
Q3 25
-10.5%
17.8%
Q2 25
-12.2%
22.4%
Q1 25
-27.5%
-16.9%
Q4 24
16.8%
-2258.9%
Q3 24
1.8%
17.2%
Q2 24
-22.4%
11.3%
Q1 24
-13.8%
8.1%
EPS (diluted)
CTKB
CTKB
FFIC
FFIC
Q4 25
$0.12
Q3 25
$0.30
Q2 25
$0.41
Q1 25
$-0.29
Q4 24
$-1.67
Q3 24
$0.30
Q2 24
$0.18
Q1 24
$0.12

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CTKB
CTKB
FFIC
FFIC
Cash + ST InvestmentsLiquidity on hand
$90.9M
Total DebtLower is stronger
Stockholders' EquityBook value
$341.7M
$708.0M
Total Assets
$461.5M
$8.7B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CTKB
CTKB
FFIC
FFIC
Q4 25
$90.9M
Q3 25
$93.3M
Q2 25
$75.5M
Q1 25
$95.3M
Q4 24
$98.7M
Q3 24
$162.3M
Q2 24
$177.9M
Q1 24
$168.8M
Stockholders' Equity
CTKB
CTKB
FFIC
FFIC
Q4 25
$341.7M
$708.0M
Q3 25
$378.6M
$711.2M
Q2 25
$377.6M
$706.4M
Q1 25
$379.6M
$702.9M
Q4 24
$395.7M
$724.5M
Q3 24
$385.5M
$666.9M
Q2 24
$389.1M
$665.3M
Q1 24
$392.6M
$669.8M
Total Assets
CTKB
CTKB
FFIC
FFIC
Q4 25
$461.5M
$8.7B
Q3 25
$494.9M
$8.9B
Q2 25
$493.3M
$8.8B
Q1 25
$482.6M
$9.0B
Q4 24
$499.5M
$9.0B
Q3 24
$491.2M
$9.3B
Q2 24
$483.7M
$9.1B
Q1 24
$492.1M
$8.8B

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CTKB
CTKB
FFIC
FFIC
Operating Cash FlowLast quarter
$-771.0K
$61.0M
Free Cash FlowOCF − Capex
$-1.8M
$55.8M
FCF MarginFCF / Revenue
-2.9%
94.9%
Capex IntensityCapex / Revenue
1.6%
8.9%
Cash ConversionOCF / Net Profit
15.16×
TTM Free Cash FlowTrailing 4 quarters
$-8.8M
$104.7M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CTKB
CTKB
FFIC
FFIC
Q4 25
$-771.0K
$61.0M
Q3 25
$-3.9M
$19.6M
Q2 25
$108.0K
$25.8M
Q1 25
$-125.0K
$6.9M
Q4 24
$2.0M
$12.4M
Q3 24
$13.2M
$5.4M
Q2 24
$6.2M
$9.6M
Q1 24
$4.0M
$-6.2M
Free Cash Flow
CTKB
CTKB
FFIC
FFIC
Q4 25
$-1.8M
$55.8M
Q3 25
$-4.6M
$19.3M
Q2 25
$-1.5M
$24.4M
Q1 25
$-974.0K
$5.2M
Q4 24
$1.1M
$10.1M
Q3 24
$12.2M
$4.8M
Q2 24
$5.2M
$8.8M
Q1 24
$3.4M
$-6.5M
FCF Margin
CTKB
CTKB
FFIC
FFIC
Q4 25
-2.9%
94.9%
Q3 25
-8.7%
33.0%
Q2 25
-3.2%
38.5%
Q1 25
-2.3%
8.9%
Q4 24
1.9%
463.4%
Q3 24
23.7%
9.3%
Q2 24
11.0%
18.7%
Q1 24
7.6%
-14.3%
Capex Intensity
CTKB
CTKB
FFIC
FFIC
Q4 25
1.6%
8.9%
Q3 25
1.3%
0.4%
Q2 25
3.5%
2.1%
Q1 25
2.0%
2.9%
Q4 24
1.6%
106.0%
Q3 24
2.0%
1.1%
Q2 24
2.3%
1.7%
Q1 24
1.3%
0.6%
Cash Conversion
CTKB
CTKB
FFIC
FFIC
Q4 25
15.16×
Q3 25
1.87×
Q2 25
1.81×
Q1 25
Q4 24
0.21×
Q3 24
14.05×
0.61×
Q2 24
1.80×
Q1 24
-1.69×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CTKB
CTKB

Products$46.6M75%
Services$15.5M25%

FFIC
FFIC

Segment breakdown not available.

Related Comparisons